de Nigris E - Search Results

1

Short- and Long-Term Impact of Prior Chronic Obstructive Pulmonary Disease Exacerbations on Healthcare Resource Utilization and Related Costs: An Observational Study (SHERLOCK).

de Nigris E, Haughney J, Lee AJ, Nath M, Müllerová H, Holmgren U, Ding B. de Nigris E, et al. COPD. 2023 Dec;20(1):92-100. doi: 10.1080/15412555.2022.2136065. Epub 2023 Jan 19. COPD. 2023. PMID: 36656661 Free article.

2

Evaluation of treatment options for patients with advanced renal cell carcinoma: assessment of appropriateness, using the validated semi-quantitative RAND corporation/University of California, Los Angeles methodology.

Gore ME, Bellmunt J, Eisen T, Escudier B, Mickisch G, Patard J, Porta C, Ravaud A, Schmidinger M, Schöffski P, Sternberg CN, Szczylik C, De Nigris E, Wheeler C, Kirpekar S. Gore ME, et al. Among authors: de nigris e. Eur J Cancer. 2012 May;48(7):1038-47. doi: 10.1016/j.ejca.2012.02.058. Epub 2012 Mar 14. Eur J Cancer. 2012. PMID: 22425264

3

Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β₂-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis.

Ferguson GT, Darken P, Ballal S, Siddiqui MK, Singh B, Attri S, Holmgren U, de Nigris E. Ferguson GT, et al. Among authors: de nigris e. Adv Ther. 2020 Jun;37(6):2956-2975. doi: 10.1007/s12325-020-01311-3. Epub 2020 Apr 25. Adv Ther. 2020. PMID: 32335859 Free PMC article.

4

Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol Fumarate versus Other Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis.

Bourdin A, Molinari N, Ferguson GT, Singh B, Siddiqui MK, Holmgren U, Ouwens M, Jenkins M, De Nigris E. Bourdin A, et al. Among authors: de nigris e. Adv Ther. 2021 Jun;38(6):3089-3112. doi: 10.1007/s12325-021-01703-z. Epub 2021 Apr 30. Adv Ther. 2021. PMID: 33929661 Free PMC article.

5

A Systematic Literature Review of the Humanistic Burden of COPD.

Hurst JR, Siddiqui MK, Singh B, Varghese P, Holmgren U, de Nigris E. Hurst JR, et al. Among authors: de nigris e. Int J Chron Obstruct Pulmon Dis. 2021 May 10;16:1303-1314. doi: 10.2147/COPD.S296696. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 34007170 Free PMC article. Review.

6

Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study.

Whittaker H, Rubino A, Müllerová H, Morris T, Varghese P, Xu Y, De Nigris E, Quint JK. Whittaker H, et al. Among authors: de nigris e. Int J Chron Obstruct Pulmon Dis. 2022 Mar 3;17:427-437. doi: 10.2147/COPD.S346591. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 35264849 Free PMC article.

7

Relationship between risk, cumulative burden of exacerbations and mortality in patients with COPD: modelling analysis using data from the ETHOS study.

Rhodes K, Jenkins M, de Nigris E, Aurivillius M, Ouwens M. Rhodes K, et al. Among authors: de nigris e. BMC Med Res Methodol. 2022 May 25;22(1):150. doi: 10.1186/s12874-022-01616-7. BMC Med Res Methodol. 2022. PMID: 35614467 Free PMC article.

8

Association of COPD exacerbations and acute cardiovascular events: a systematic review and meta-analysis.

Müllerová H, Marshall J, de Nigris E, Varghese P, Pooley N, Embleton N, Nordon C, Marjenberg Z. Müllerová H, et al. Among authors: de nigris e. Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221113647. doi: 10.1177/17534666221113647. Ther Adv Respir Dis. 2022. PMID: 35894441 Free PMC article.

9

Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review.

Hurst JR, Han MK, Singh B, Sharma S, Kaur G, de Nigris E, Holmgren U, Siddiqui MK. Hurst JR, et al. Among authors: de nigris e. Respir Res. 2022 Aug 23;23(1):213. doi: 10.1186/s12931-022-02123-5. Respir Res. 2022. PMID: 35999538 Free PMC article. Review.

10

Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent postdiagnosis COPD exacerbations and mortality: EXACOS-UK health care data study.

Whittaker H, Nordon C, Rubino A, Morris T, Xu Y, De Nigris E, Müllerová H, Quint JK. Whittaker H, et al. Among authors: de nigris e. Thorax. 2023 Aug;78(8):760-766. doi: 10.1136/thorax-2022-219039. Epub 2022 Oct 31. Thorax. 2023. PMID: 36316117 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters